Brain dysfunction including coma and delirium was evaluated by the Glasgow Coma Score (GCS) or the Richmond Agitation Sedation Scale (RASS) combined with the Confusion Assessment Method in the ICU (CAM-ICU) and with the measurement of serum biomarker of brain injury S100B protein [13]. Here, S100B is linked to type 2 diabetes mellitus.